The largest database of trusted experimental protocols
Protocol detail

Evaluating DNA Polymerase Fidelity in GS20 Sequencing

The GS20 emPCR process incorporates the use of the high-fidelity polymerase, Platinum Taq Hifidelity (Invitrogen), an enzyme mixture composed of recombinant Taq DNA polymerase, Pyrococcus spp. GB-D thermostable polymerase and Platinum Taq antibody. This enzyme is marketed partly on its very low misincorporation rate, 2 × 10−6 (Invitrogen). In this study we find the actual rate of misincorporation to be higher (≈7 × 10−4), similar to results from a previous aDNA study that has also specifically examined these properties of this enzyme (8 (link)). To discriminate between true aDNA damage and enzyme error or potential damage that may have arisen during the DNA extraction or that may have been present in the DNA before extraction, we analysed a further dataset of GS20 sequences, generated from a modern DNA extract, comprising 390 965 bp of L.tulipfera cpDNA. These data are part of the first chloroplast genome sequenced using the GS20 (J.E. Carlson, J.H. Leebens-Mack and D.G. Peterson, manuscript in preparation) and constitutes all the sequence reads between np 45 000 and 90 000 of the genome (J.E. Carlson, J.H. Leebens-Mack and S. Schuster, unpublished data). Although we are aware that in theory some complications may be envisioned when comparing cpDNA with mtDNA, at the current time there is a paucity of available datasets that contain sufficiently large amounts of sequence data to enable meaningful statistical comparisons. Thus this dataset provides the most suitable information at this time. The data analysed here have maximal coverage of 36 times, with a mean and modal coverage of 8.7 and 8 times, respectively. The L.tulipfera cpDNA sequences are available at the NCBI Trace Archives (Trace Identifiers 1367656065–1367659980). Analysis of the genomic data produced indicates that levels of heteroplasmy in the sample are negligible, thus unlikely to effect the analyses (J.E. Carlson, J.H. Leebens-Mack and S. Schuster, unpublished data). Furthermore, as DNA from this sample was freshly extracted from modern tissue, miscoding lesions observed in the data are unlikely to be due to anything other than PCR or other sequencing error that arises during the GS20 data production process. The miscoding lesion spectrum was extracted from the data in the same manner as applied to the mtDNA data. For data summary see Table 1.
A χ2-test of independence was used to investigate whether the distribution of miscoding lesions was the same in the mammoth and chloroplast sequence data. The data were first summarized into six complementary damage pairs (Table 1). Subsequently, because nucleotide usage is different between the mammoth and chloroplast data, tests were performed separately on those miscoding lesions that originated from an A or T (A+T), and those that originated from a G or C (G+C).

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Publication 2006
Adna Antibody Chloroplast Chloroplast genome Cpdna Enzyme Gb d polymerase Genomic Heteroplasmy Mammoth Mtdna Nucleotide Platinum Pyrococcus Taq dna polymerase Tissue

Corresponding Organization :

Other organizations : University of Copenhagen, Pennsylvania State University, Aarhus University Hospital, McMaster University, University of Georgia

Protocol cited in 15 other protocols

1

VRK1 Depletion Across Cell Lines

The depletion of VRK1 by siRNA has been previously reported for A549 [20 (link), 23 (link)], H1299 [20 (link), 23 (link)], MDA-MB-231 [26 (link)] and HT144 [23 (link), 24 (link)] cell lines. Specific VRK1 knockdown was performed using siVRK1–02 from DHARMACON RNA Technologies. The target sequences of this siVRK1–02 is the following one (5′ to 3′): CAAGGAACCUGGUGUUGAA. The “ON-TARGETplus siCONTROL Non-targeting siRNA” from DHARMACON was used as negative control (siCtrl) [31 (link)]. Briefly, cells were transfected with the indicated siRNA at a concentration of 20 nM using either Lipofectamine 2000 (Invitrogen) or Lipotransfectin (Nivorlab), following manufacturer’s instructions [25 (link), 31 (link), 32 (link)].
+ Open protocol
2

VRK1 and Sox2 Knockdown in Cells

VRK1 knockdown was performed using three different siRNA for VRK1 (NM_003384): siVRK1-02 (siV1-02), siVRK1-03 (siV1-03) and siVRK1-09 (siV1-09) (Dharmacon RNA Technologies,). The sequences targeted by these VRK1 siRNA oligonucleotides were siVRK1-01: GAAAGAGAGTCCAGAAGTA; siVRK1-02: CAAGGAACCTGGTGTTGAA; si-VRK1-03: GGAAUGGAAAGUAGGAUUA; and siVRK1-09: AGGUGUACUUGGUAGAUUA. Sox2 was knockdown with the SOX2 Trilencer-27 human siRNA (Origene, Rockville, MD). As negative control the “ON-TARGETplus siCONTROL Non-targeting siRNA” (siCt) (Dharmacon) was used. The efficiency of RNAi transfection was determined with “siGLO RISC-free siRNA” (DHARMACON) labelled with a red fluorochrome. All of them have been previously used. Cells were transfected with the indicated siRNA (20 nM), using Lipofectamine 2000 (Invitrogen; Carlsbad, CA) as previously reported16 (link)17 (link)28 (link)38 (link)57 (link).
+ Open protocol

Variable analysis

dependent variables
  • Rate of misincorporation
  • Miscoding lesion spectrum
control variables
  • Modern DNA extract of Liriodendron tulipifera chloroplast DNA
controls
  • Positive control: not explicitly mentioned
  • Negative control: not explicitly mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
Sign up for free or login to display all annotations

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!